Skip to main content

Table 2 Antiretroviral therapy in 81 cases and 162 controls

From: Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy

  Cases n (%) Controls n (%) p
First line therapy 81 (100) 162 (100)  
Combinations    
-NRTI+PI 67 (83) 138 (85) 0.7
-NRTI+NNRTI 14 (17) 26 (16) 0.7
Duration; months (mean ± SD) 13.46 ± 10.23 16.67 ± 8.45 0.06
N° of patients who suspended 53 (66) 91 (56) 0.2
Cause of suspension    
-side effects 30 (56) 37 (41) 0.1
-viro-immunological failure 8 (15) 15 (17) 0.6
Second line therapy 45 (56) 91 (56) 1
Third line therapy 11 (14) 31 (19) 0.4
Total number of drug changes (mean ± SD) 2.1 ± 0.9 2.0 ± 0.6 0.8,
Adherent to the last drug regimen 68 (84) 118 (73) 0.08
Side effects to HAART    
dyslipidemia 32 (40) 55 (34) 0.5
digestive intolerance 26 (32) 58 (36) 0.6
lipodystrophy 12 (15) 23 (14) 0.7
hyperglycaemia 8 (10) 3 (2) 0.01
anaemia 8 (10) 3 (2) 0.01